AI assistant
Sending…
BiomX Inc. — Director's Dealing 2025
Mar 4, 2025
35099_dirs_2025-03-04_99a3cb67-0808-465f-94d3-dcbe99d2922f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2025-02-26
Reporting Person: Cystic Fibrosis Foundation (N/A)
More from BiomX Inc.
Transaction in Own Shares
2026
Jun 5
Board/Management Information
2026
May 28
Interim / Quarterly Report
2026
May 20
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 16
Capital/Financing Update
2026
Apr 13
Regulatory Filings
2026
Apr 10
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 10
Regulatory Filings
2026
Apr 10
Capital/Financing Update
2026
Apr 1